13 results
·
27ms
·
Sources: EU EUDAMED, US FDA
ISOTECHNOLOGIES LIFTSTATION & LIFTWORKS SOFTWARE
FDA 510(k)
FDA Class 2
·Physical Medicine
REVELATION DIAMOND
FDA UDI
Ss White Burs, Inc.·D6909121752·REVELATION DIAMOND 834-016M - 5 PACK
NA
FDA UDI
Stryker Leibinger GmbH & Co. KG·04546540364685·AUXILIARY SCREW MODULE, 1.2/1.7MM
Gen. Acces/ Instr. Tip Guard
FDA UDI
KATENA PRODUCTS, INC.·00841668110850·TIP GUARDS VENTED WHITE PACK OF 100
Malibu
FDA UDI
Seaspine Orthopedics Corporation·10889981080983·Tap 6.0mm (for 6.5mm Screw)
On Call Express II Blood Glucose Monitoring System
FDA 510(k)
FDA Class 2
·Clinical Chemistry
PASS SPINAL SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
POWERED WHEELCHAIR
FDA Adverse Event
Malfunction
·INVACARE TAYLOR STREET·Product code ITI·January 11, 2013
SPRINT QUATTRO SECURE
FDA Adverse Event
Death
·MEDTRONIC PUERTO RICO, INC.·Product code LWS·December 2, 2010
ACUITY
FDA Adverse Event
Injury
·CPI - DEL CARIBE·Product code OJX·July 3, 2014
OPTETRAK Comprehensive Knee System including OPTETRAK RBK PS Tibial Components. NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·October 13, 2021
PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017
PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017